← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1 · 임상 갱신 필요 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV14행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestalePhase 1
UCB-NK cells (UCB-NK cells)
Dutch Cancer Society·Recurrent Ovarian Carcinoma
16 trials
Overview
Program
UCB-NK cells
Overview
Company
Dutch Cancer Society
Overview
Modality
CGT
Overview
Target
Recurrent Ovarian Carcinoma
Overview
Indication
Recurrent Ovarian Carcinoma; Recurrent Fallopian Tube Carcinoma
Overview
Phase
PHASE_1
Overview
Status
ACTIVE
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Watch
Overview
Approval status
Investigational
Toxicology
Major finding
Exploring the correlation and mechanism of natural killer cell cytotoxic sensitivity against gastric cancer.. Human natural killer (NK) cells have attracted widespread attention as a potential adoptive cell therapy (ACT). However, the therapeutic effects of NK cell infusion in patients with solid tumors are limited. There is an urgent need to explore a suitable new treatment plan to overcome weakn…
Clinical
Safety signal
Exploring the correlation and mechanism of natural killer cell cytotoxic sensitivity against gastric cancer.. Human natural killer (NK) cells have attracted widespread attention as a potential adoptive cell therapy (ACT). However, the therapeutic effects of NK cell infusion in patients with solid tumors are limited. There is an urgent need to explore a suitable new treatment plan to overcome weakn…
Clinical
Program phase
PHASE_1